Searched for
BIOPHARMACEUTICAL UNIT RESTRUCTURING
When investing for the long term, parentage matters: 6 stocks that fit the bill, 5 with an upside potential of more than 34%- Morgan Stanley, Walmart, Pfizer and more: Full list of over 150 American companies laying off employees in June
- MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%
- Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...24 Feb, 2025, 06.10 PM IST
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...20 Feb, 2025, 06.11 PM IST
- AstraZeneca India recasts biopharma unitAstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. T...30 Dec, 2024, 12.09 AM IST
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...03 Dec, 2024, 04.06 PM IST
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...15 Aug, 2024, 03.07 PM IST
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...24 Jun, 2024, 04.53 PM IST
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...23 Feb, 2024, 03.29 PM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- After long phase of consolidation: 4 Indian pharma stocks with upside potential of up to 41%Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...12 Dec, 2023, 12.43 PM IST
- A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...29 Aug, 2023, 12.46 PM IST
- Finally out of the woods? 5 small and midcap pharma stocks with an upside potential of up to 23%Pharma as a sector, both in terms of business and stocks price performance has been under pressure for a very long time. Some time USFDA is...22 Aug, 2023, 02.42 PM IST
- Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...06 Aug, 2023, 12.57 PM IST
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...25 Apr, 2023, 01.31 PM IST
- Biocon's biosimilars progressAnalysts gave a thumbs up to Biocon after the company said its copy of biopharmaceutical insulin glargine met the primary targets, which in...29 Apr, 2016, 12.47 PM IST
- Vyome Biosciences closes $8 million funding roundProceeds from the Series B round of funding will be used to drive the completion of critical milestones of US Food and Drug Administration ...11 Aug, 2014, 07.38 PM IST
- Wockhardt sells nutritionals biz to AbbottWockhardt has sold its nutritionals business comprising top-selling brands Farex, Protinex, Dexolac and Nusobee, and manufacturing units at...29 Jul, 2009, 01.12 AM IST
- Bristol-Myers to shut half of its plants in 3 yearsApart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...07 Dec, 2007, 01.11 AM IST
Load More
